National Eye Institute (NEI): Retinal Diseases trials

The registry lists 35 Retinal Diseases studies with National Eye Institute (NEI) as lead sponsor. 3 are open to participants now and 5 have results posted.

Early Phase 1 1Phase 1 6Phase 2 9Phase 3 7No phase 17(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• National Eye Institute Biorepository for Retinal DiseasesRecruitingNCT01496625
• Cell Collection to Study Eye DiseasesRecruitingNCT01432847
• Genotype-Phenotype Study of Patients With Plaquenil -Induced Retinal Toxicity, With Evaluation of the ABCA4 GeneRecruitingNCT01145196
• Finasteride for Chronic Central Serous ChorioretinopathyTerminatedNCT01585441Phase 2Results posted
• Topical Interferon Gamma-1b for Central Serous ChorioretinopathyCompletedNCT01468337Phase 1/2Results posted
• Extension Study for the Evaluation of Finasteride in the Treatment of Chronic Central Serous ChorioretinopathyCompletedNCT01227993Phase 1/2Results posted
• Pilot Study for the Evaluation of Finasteride in the Treatment of Chronic Central Serous ChorioretinopathyCompletedNCT00837252Phase 1/2Results posted
• Sirolimus to Treat Diabetic Macular EdemaCompletedNCT00711490Phase 1/2Results posted
• Color Vision as a Measure for Inherited Retinal DiseasesCompletedNCT01878032
• Evaluation of Single Nucleotide Polymorphisms (SNPs) in Patients With and Without Diabetic Macular EdemaTerminatedNCT01168258
• Rituximab for Autoimmune RetinopathyCompletedNCT01086631Phase 1
• Genetics and Markers of Degenerative and Inflammatory Eye DiseasesCompletedNCT00647439
• Vascular Remodeling and the Effects of Angiogenic Inhibition in Diabetic RetinopathyCompletedNCT00411333Early Phase 1
• Metabolic Mapping to Measure Retinal MetabolismCompletedNCT00385333Phase 2
• Triamcinolone Acetonide Injections to Treat Diabetic Macular EdemaCompletedNCT00231023Phase 2
• Clinical and Genetic Studies of Familial Exudative VitreoretinopathyCompletedNCT00106756
• Intravitreal v. Sub-tenon Injections of Triamcinolone Acetonide for Macular Edema in Retinal DisordersCompletedNCT00101764Phase 1
• Optical Coherence Tomography Comparative StudyCompletedNCT00069199
• The Early Treatment for Retinopathy of Prematurity Study (ETROP)Status unknownNCT00027222Phase 2/3
• Evaluation and Treatment of Patients With Inflammatory Eye DiseasesCompletedNCT00006188
• Evaluation and Treatment of Patients With Retinal DiseaseCompletedNCT00005784
• Blood Factors and Diabetic RetinopathyCompletedNCT00005761
• HAT in Eye Complications of Behcet's DiseaseCompletedNCT00001865Phase 2
• Screening for Studies on Retinovascular DiseasesCompletedNCT00001733
• Long-Term Follow-Up of Patients Enrolled in the Early Treatment Diabetic Retinopathy Study (ETDRS)CompletedNCT00001612
• Long Term Follow-Up of Diabetic RetinopathyCompletedNCT00001395
• Diabetic Retinopathy and Visual Function StudyCompletedNCT00001346
• Tissue Studies of Human Eye DiseasesTerminatedNCT00001310
• Diabetic Retinopathy Study (DRS)CompletedNCT00000160Phase 3
• Sorbinil Retinopathy Trial (SRT)CompletedNCT00000159Phase 3
• The Effects of Light Reduction on Retinopathy of Prematurity (Light-ROP)CompletedNCT00000156Phase 3
• Diabetic Retinopathy Vitrectomy Study (DRVS)CompletedNCT00000154Phase 3
• Early Treatment Diabetic Retinopathy Study (ETDRS)CompletedNCT00000151Phase 3
• Cryotherapy for Retinopathy of Prematurity (CRYO-ROP) - Outcome Study of Cryotherapy for Retinopathy of PrematurityCompletedNCT00000133Not applicable
• Central Vein Occlusion Study (CVOS)CompletedNCT00000131Phase 3